Cargando…

HER2 classification in breast cancer cells: A new explainable machine learning application for immunohistochemistry

The immunohistochemical (IHC) evaluation of epidermal growth factor 2 (HER2) for the diagnosis of breast cancer is still qualitative with a high degree of inter-observer variability, and thus requires the incorporation of complementary techniques such as fluorescent in situ hybridization (FISH) to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordova, Claudio, Muñoz, Roberto, Olivares, Rodrigo, Minonzio, Jean-Gabriel, Lozano, Carlo, Gonzalez, Paulina, Marchant, Ivanny, González-Arriagada, Wilfredo, Olivero, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811637/ https://www.ncbi.nlm.nih.gov/pubmed/36644146 http://dx.doi.org/10.3892/ol.2022.13630

Ejemplares similares

Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients
por: Lozano, Carlo, et al.
Publicado: (2018)

Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives
por: Olivero, Pablo, et al.
Publicado: (2018)

Transient Receptor Potential Vanilloid 1 Expression Mediates Capsaicin-Induced Cell Death
por: Ramírez-Barrantes, Ricardo, et al.
Publicado: (2018)

TRPV1-Estradiol Stereospecific Relationship Underlies Cell Survival in Oxidative Cell Death
por: Ramírez-Barrantes, Ricardo, et al.
Publicado: (2020)

TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration
por: Ramírez-Barrantes, Ricardo, et al.
Publicado: (2016)

Estrogen rapid effects: a window of opportunity for the aging brain?
por: Marchant, Ivanny, et al.
Publicado: (2022)

Estrogen, Cognitive Performance, and Functional Imaging Studies: What Are We Missing About Neuroprotection?
por: Marchant, Ivanny Carolina, et al.
Publicado: (2022)

Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth
por: Domingueti, Catherine-Bueno, et al.
Publicado: (2019)

Is HER2 amplification predictable by digital immunohistochemistry?
por: Micsik, Tamás, et al.
Publicado: (2013)

Oral lichen planus interactome reveals CXCR4 and CXCL12 as candidate therapeutic targets
por: Rivera, César, et al.
Publicado: (2020)

Difficulties in the Prognostic Study of Oral Leukoplakia: Standardisation Proposal of Follow-Up Parameters
por: Saldivia-Siracusa, Cristina, et al.
Publicado: (2021)

Perineural invasion predicts poor survival and cervical lymph node metastasis in oral squamous cell carcinoma
por: Martínez-Flores, René, et al.
Publicado: (2023)

Classification of Contraction Bands Using Immunohistochemistry
por: Morita, Satomu, et al.
Publicado: (2015)

Round Cell Tumors: Classification and Immunohistochemistry
por: Sharma, Shweta, et al.
Publicado: (2017)

Meningioma classification by immunohistochemistry: A replicability study
por: Näslund, Olivia, et al.
Publicado: (2022)

Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity
por: Ramírez-Barrantes, R., et al.
Publicado: (2016)

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
por: Morsberger, Laura, et al.
Publicado: (2022)

Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis
por: Margolskee, Elizabeth, et al.
Publicado: (2016)

High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
por: Marchant, Ivanny, et al.
Publicado: (2015)

MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review
por: Niklander, Sven, et al.
Publicado: (2022)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
por: Chen, Hai-long, et al.
Publicado: (2021)

Plasmablastic lymphoma as a manifestation of the human immunodeficiency virus: Case report
por: Vera, Gonzalo, et al.
Publicado: (2020)

Detection of Her-2/neu expression in gastric cancer: Quantitative PCR versus immunohistochemistry
por: ZHU, GUANG-JUN, et al.
Publicado: (2014)

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics
por: Petroni, Stella, et al.
Publicado: (2016)

A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry
por: Guo, Qianqian, et al.
Publicado: (2017)

Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
por: Ardor, Gokce Deniz, et al.
Publicado: (2023)

Are There More HER2 FISH in the Sea? An Institution’s Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
por: Suydam, Camille, et al.
Publicado: (2023)

Fine needle cytology features of an atypical presentation of infectious mononucleosis
por: Gerber-Mora, Roberto, et al.
Publicado: (2020)

Virtual Patients and Sensitivity Analysis of the Guyton Model of Blood Pressure Regulation: Towards Individualized Models of Whole-Body Physiology
por: Moss, Robert, et al.
Publicado: (2012)

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer
por: Nistor, Andreea, et al.
Publicado: (2006)

HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer
por: Bae, Young Kyung, et al.
Publicado: (2012)

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Immunohistochemistry of mammary Paget’s disease: Cytokeratin 7, GATA3, and HER2 are sensitive markers
por: Arain, Shoukat A., et al.
Publicado: (2020)

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases
por: Carretero-Barrio, Irene, et al.
Publicado: (2023)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray
por: Zhao, Chong, et al.
Publicado: (2020)

Low Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus
por: Rygiel, Agnieszka M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l5rdu7aku25ff2jrmbgmsutfoa